Vertex Pharmaceuticals Inc
XMUN:VX1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
V
|
Vertex Pharmaceuticals Inc
XMUN:VX1
|
US |
|
D
|
Daimler Truck Holding AG
XMUN:DTG
|
DE |
|
ASML Holding NV
MIL:1ASML
|
NL |
|
A
|
Advanced Micro Devices Inc
BMV:AMD
|
US |
Wall St Price Targets
VX1 Price Targets Summary
Vertex Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for VX1 is 473.73 EUR with a low forecast of 282.66 EUR and a high forecast of 570.78 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is VX1's stock price target?
Price Target
473.73
EUR
According to Wall Street analysts, the average 1-year price target for VX1 is 473.73 EUR with a low forecast of 282.66 EUR and a high forecast of 570.78 EUR.
What is the Revenue forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
10%
Over the last 14 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 8 years is 10%.
What is the Operating Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
15%
Over the last 14 years, the compound annual growth rate for Operating Income has been 24%. The projected CAGR for the next 8 years is 15%.
What is the Net Income forecast for Vertex Pharmaceuticals Inc?
Projected CAGR
15%
Over the last 14 years, the compound annual growth rate for Net Income has been 42%. The projected CAGR for the next 8 years is 15%.
